In 2018, the Baldwins began a journey they never could have imagined. Their 9-year-old son Bryce had fallen down on a family trip to Holiday World, and in the weeks following, they noticed some right ...

Mathematics may not be the first thing people associate with Alzheimer’s disease research. But for Pedro Maia, an assistant ...

From radiation exposure to trauma and injury, here are a few causes of sarcoma cancer that develops in the connective tissues of the body.

The European Commission has approved EZMEKLY (mirdametinib) for treatment of symptomatic, inoperable plexiform neurofibromas ...

The European Commission (EC) has granted conditional approval to SpringWorks Therapeutics’ Ezmekly (mirdametinib) to treat ...

The new approval will help Merck make a return on its $3.9 billion investment in acquiring SpringWorks, which has operated as ...

From dietary patterns to side effects of common medications, know how glioblastoma can develop in young adults.

The event, hosted by NF Network, included a 5K walk/run, a basket raffle and a time to share and spread awareness ...

The European Commission granted conditional marketing authorization for Ezmekly (mirdametinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric and adult patients ...

Brain tumor is a serious health problem, which often emerges slowly and its symptoms may seem minor in the beginning. Some ...

Merck KGaA said its Ezmekly therapy for people with a rare genetic disorder has received the conditional marketing approval from the European Commission. The pharmaceutical company said Friday that ...

EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) ...